New drugs under development for COPD
Author:
Publisher
Edizioni Minerva Medica
Subject
General Medicine
Link
https://www.minervamedica.it/pdf.php?cod=R10Y2022N03A0471
Reference200 articles.
1. Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
2. Molecular links between COPD and lung cancer: new targets for drug discovery?
3. Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
4. High-dimensional profiling clusters asthma severity by lymphoid and non-lymphoid status
5. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pulmonary delivery of magnolol-loaded nanostructured lipid carriers for COPD treatment;International Journal of Pharmaceutics;2024-09
2. Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression;International Journal of Molecular Sciences;2024-08-19
3. ZC3H13 promotes ITGA6 m6A modification for chronic obstructive pulmonary disease progression;Cellular Signalling;2024-08
4. Causal relationships of physical activity and leisure sedentary behaviors with COPD: A Mendelian randomization study;Archives of Gerontology and Geriatrics;2024-06
5. Down-regulation of RTEL1 Improves M1/M2 Macrophage Polarization by Promoting SFRP2 in Fibroblasts-derived Exosomes to Alleviate COPD;Cell Biochemistry and Biophysics;2024-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3